Clinical Trial Update: The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial of ranolazine for atrial fibrillation and diastolic heart failure was terminated. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Atrial Fibrillation, Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2015-07-20